TrialAntimicrobial agents and chemotherapy2020

A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein.

John DeVincenzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.